The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumour tropism

被引:41
作者
Collins, EC [1 ]
Rabbitts, TH [1 ]
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
关键词
D O I
10.1016/S1471-4914(02)02397-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MLL is a promiscuous gene involved in a diversity of chromosomal fusions in haematological malignancies, usually resulting from chromosomal translocations. MLL-associated chromosomal rearrangements usually occur in tumours of specific haematological lineages, suggesting a crucial role for the MLL fusion partner in determining disease phenotype (or tumour tropism). The MLL gene is homologous to Drosophila trithorax, and is likewise involved in embryo pattern formation. Common themes linking several of the MLL partners include a possible involvement in embryo patterning via Hoxgene regulation and chromatin remodelling. These findings reinforce the link between developmental regulation and chromosomal translocations, and indicate the role of chromosomal translocation in activating genes capable of determining tumour phenotype in leukaemias and sarcomas.
引用
收藏
页码:436 / 442
页数:7
相关论文
共 72 条
  • [1] MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
    Armstrong, SA
    Staunton, JE
    Silverman, LB
    Pieters, R
    de Boer, ML
    Minden, MD
    Sallan, SE
    Lander, ES
    Golub, TR
    Korsmeyer, SJ
    [J]. NATURE GENETICS, 2002, 30 (01) : 41 - 47
  • [2] Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins
    Ayton, PM
    Cleary, ML
    [J]. ONCOGENE, 2001, 20 (40) : 5695 - 5707
  • [3] The CBP co-activator is a histone acetyltransferase
    Bannister, AJ
    Kouzarides, T
    [J]. NATURE, 1996, 384 (6610) : 641 - 643
  • [4] BREEN TR, 1993, DEVELOPMENT, V117, P119
  • [5] Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: Correlation with scaffold attachment regions and topoisomerase II consensus binding sites
    Broeker, PLS
    Super, HG
    Thirman, MJ
    Pomykala, H
    Yonebayashi, Y
    Tanabe, S
    ZeleznikLe, N
    Rowley, JD
    [J]. BLOOD, 1996, 87 (05) : 1912 - 1922
  • [6] Buske C, 2000, INT J HEMATOL, V71, P301
  • [7] Busson-Le Coniat M, 1999, LEUKEMIA, V13, P302
  • [8] The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures
    Butler, LH
    Slany, R
    Cui, XM
    Cleary, ML
    Mason, DY
    [J]. BLOOD, 1997, 89 (09) : 3361 - 3370
  • [9] Cairns BR, 1996, MOL CELL BIOL, V16, P3308
  • [10] A MULTISUBUNIT COMPLEX CONTAINING THE SWI1/ADR6, SWI2/SNF2, SWI3, SNF5, AND SNF6 GENE-PRODUCTS ISOLATED FROM YEAST
    CAIRNS, BR
    KIM, YJ
    SAYRE, MH
    LAURENT, BC
    KORNBERG, RD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (05) : 1950 - 1954